Combination of a transdermal therapeutic system and an oral and/or parenteral preparation containing dopamine agonists for the treatment of dopaminergic disease states

Details for Australian Patent Application No. 2001295512 (hide)

Owner Neurobiotec GmbH

Inventors Horowski, Reinhard; Tack, Johannes

Agent Davies Collison Cave

Pub. Number AU-B-2001295512

PCT Pub. Number WO02/34267

Priority 10053397 20.10.00 DE

Filing date 24 August 2001

Wipo publication date 6 May 2002

Acceptance publication date 21 September 2006

International Classifications

A61K 31/48 (2006.01) - Ergoline derivatives, e.g. lysergic acid, ergotamine

A61K 9/70 (2006.01) Medicinal preparations characterised by special physical form - Web, sheet or filament bases

Event Publications

21 September 2006 Application Accepted

  Published as AU-B-2001295512

18 January 2007 Standard Patent Sealed

21 June 2007 Assignment Registered

  Neurobiotec GmbH The patent has been assigned to Axxonis Pharma AG

24 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001295513

2001295511